Therapeutic Nanoparticles to Combat Cancer Drug Resistance

E-ISSN： 1875-5453|10|8|836-841

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.10, Iss.8, 2009-10, pp. : 836-841

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug resistance in cancer – searching for mechanisms, markers and therapeutic agents

By O'Connor Robert Clynes Martin Dowling Paul O'Donovan Norma O'Driscoll Lorraine

Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, Iss. 6, 2007-12 ,pp. : 805-817

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA-21: a therapeutic target for reversing drug resistance in cancer

By Hong Liu

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 9, 2013-09 ,pp. : 1073-1080

Informa Healthcare

Access to resources Recommend Favorite

Nanoparticles in the Development of Therapeutic Cancer Vaccines

Pharmaceutical Nanotechnology, Vol. 2, Iss. 1, 2014-03 ,pp. : 2-22

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-drug resistance and cancer

By Atalay Can

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite

Genomics and Cancer Drug Resistance

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 5, 2012-04 ,pp. : 651-673

Bentham Science Publishers

Access to resources Recommend Favorite